$23.90
-1.20 (-4.78%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+5.2% upside
Low Target
$17.03
Average Target
$25.14
High Target
$37.02
Current Price
$23.90
Current
$23.90
$23.90
Target
$25.14
$25.14
$17.03
$25.14 avg
$37.02
Scenario Analysis
Bear Case
$17.03
-28.7%
Low target
Base Case
$25.14
+5.2%
Avg target
Bull Case
$37.02
+54.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$43.66
-45.3% from high
52-Week Low
$15.93
+50.0% from low
Target vs 52W High
$25.14
-42.4% vs high
Next Earnings Report
Nov 23, 2026 · Before Market Open
9d
until earnings
EPS Est: $-1.39
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |